Skip to content

A study to compare the role of individualized homoeopathic medicines vs chimaphila umbellata in cases of urinary tract infection

A Randomised Comparative Interventional Study To Assess the efficacy of Individualized Homoeopathic medicines vis a vis chimaphila umbellata in cases of urinary tract infection using UTISA Questionnaire

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043379
Enrollment
80
Registered
2022-06-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N309- Cystitis, unspecified Health Condition 2: N341- Nonspecific urethritis

Interventions

Intervention1: Individulized Homoeopathic medicines: By using randomization list , one group will be given homoeopathic medicines after totality of symptoms and repertorization Control Intervention1:

Sponsors

Dr Girendra Pal Homoeopathic Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: At least 2 to 3 of the following symptoms must be present 1 Acute dysuria or acute pain, swelling or acute tenderness of testes epididymis or prostate 2 Fever or leukocytosis 3 Acute costovertebral angle pain tenderness 4 Suprapubic pain 5 Gross haematuria 6 Incontinence of urine 7 Increase in urgency 8 Increase in frequency of urination Urine culture bacteriuria with equal to or greater than 105 cfu/ml Patients of both sexes between age group of 18-60 years irrespective of their occupation religion and socio-economic status will be enrolled for the study Patient who give their consent for study

Exclusion criteria

Exclusion criteria: Pregnant and lactating mothers will be excluded from the study Patient suffering with impaired renal function Patient suffering with diseases having gross pathological changes and malignancies Patients who received treatment with antibiotics within 48 hrs prior to entry patient who denied for the consent

Design outcomes

Primary

MeasureTime frame
Primary outcome of the study will be based on the before and after scores of UTISA QuestionnaireTimepoint: UTISA Questionnaire will be used to assess the symptoms every week on each follow up

Secondary

MeasureTime frame
to asses the extent of improvement in both groups on the basis of routine microscopic urine examinationTimepoint: Investigation will be done after three months of first prescription

Countries

India

Contacts

Public ContactBhavneet Kaur

Homoeopathy University

drvirendrachauhan34@gmail.com9983548853

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026